← Return to 72 hours out from robotic prostate surgery ..
Discussion72 hours out from robotic prostate surgery ..
Prostate Cancer | Last Active: Jun 22 11:40am | Replies (32)Comment receiving replies
Replies to "Jeff, I could not find that new guidance about ADT and 4+7 on NCCN site -..."
Connect

From NCCN Guidelines Version 1.2025
For unfavorable intermediate-risk (4+3) prostate cancer treated with RT, short-term ADT (ST-ADT) (4- 6 months is recommended. Concurrent/adjuvant ADT is preferred over neoadjuvant ADT in this setting.
And further info from NCCN
In summary, ADT is a recommended treatment option for unfavorable intermediate-risk Gleason 7 prostate cancer, usually in combination with radiation therapy. However, treatment decisions should always be made through shared decision-making with a healthcare provider, taking into account individual patient factors and the specifics of the cancer.